Skip to content
Octocog alfa
Advate, Kovaltry (octocog alfa) is a protein pharmaceutical. Octocog alfa was first approved as Kogenate bayer on 2000-08-04. It has been approved in Europe to treat hemophilia a.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
hemic and lymphatic diseasesD006425
hereditary congenital and neonatal diseases and abnormalitiesD009358
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
138 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hemophilia aD006467EFO_0007267D661713402636125
Von willebrand diseasesD014842D68.011619
Blood coagulation disordersD001778EFO_0009314D68.91124
Hemophilia bD002836D671113
Hematologic diseasesD006402EFO_0005803D75.9213
Blood platelet disordersD00179111
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Bone diseasesD001847M89.911
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Joint diseasesD007592HP_0003040M12.911
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameOCTOCOG ALFA
INNoctocog alfa
Description
Factor VIII is a medication used to treat and prevent bleeding in people with hemophilia A and other causes of low factor VIII. Certain preparations may also be used in those with von Willebrand's disease. It is given by slow injection into a vein.
Classification
Protein
Drug class
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID139076-62-3
RxCUI1300486
ChEMBL IDCHEMBL2108455
ChEBI ID
PubChem CID
DrugBankDB00025
UNII IDP89DR4NY54 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
Advate - Takeda
$
£
Mock data
Subscribe for the real data
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 518 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
22,419 adverse events reported
View more details